About SynCardia
SynCardia is a company based in Tucson (United States) founded in 2001 was acquired by Picardmedia.de in September 2021.. SynCardia has raised $60.96 million across 11 funding rounds from investors including Delta Electronics, SWK Holdings and Athyrium Capital Management. SynCardia offers products and services including SynCardia Total Artificial Heart and Emperor Total Artificial Heart. SynCardia operates in a competitive market with competitors including CVRx, Sequana Medical, Adona Medical, Element Science and V-Wave, among others.
- Headquarter Tucson, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Syncardia Systems, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$60.96 M (USD)
in 11 rounds
-
Latest Funding Round
-
Investors
Delta Electronics
& 5 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SynCardia
SynCardia offers a comprehensive portfolio of products and services, including SynCardia Total Artificial Heart and Emperor Total Artificial Heart. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Temporary replacement for failing hearts in transplant-eligible patients.
Next-generation implantable heart for end-stage cardiac failure support.
Funding Insights of SynCardia
SynCardia has successfully raised a total of $60.96M across 11 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Last Round
-
First Round
First Round
(16 May 2003)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2015 | Amount | Series E - SynCardia | Valuation | Delta Electronics |
|
| Oct, 2014 | Amount | Series E - SynCardia | Valuation |
investors |
|
| Dec, 2013 | Amount | Series E - SynCardia | Valuation | SWK Holdings , Athyrium Capital Management |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SynCardia
SynCardia has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Delta Electronics, SWK Holdings and Athyrium Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Tech focused early stage VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Versa Capital is focused on private equity investments for business transformation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SynCardia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SynCardia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Syncardia Comparisons
Competitors of SynCardia
SynCardia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CVRx, Sequana Medical, Adona Medical, Element Science and V-Wave, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Implantable technology for hypertension and heart failure is developed.
|
|
| domain | founded_year | HQ Location |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for heart failure management are developed.
|
|
| domain | founded_year | HQ Location |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| domain | founded_year | HQ Location |
Implantable inter-atrial shunts are developed to treat chronic heart failure.
|
|
| domain | founded_year | HQ Location |
Minimally invasive ventriculoplasty system for heart failure and FMR
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Syncardia
Frequently Asked Questions about SynCardia
When was SynCardia founded?
SynCardia was founded in 2001 and raised its 1st funding round 2 years after it was founded.
Where is SynCardia located?
SynCardia is headquartered in Tucson, United States. It is registered at Tucson, Arizona, United States.
Is SynCardia a funded company?
SynCardia is a funded company, having raised a total of $60.96M across 11 funding rounds to date. The company's 1st funding round was a Series E of $14M, raised on May 16, 2003.
What does SynCardia do?
SynCardia Systems has developed a temporary total artificial heart in two sizes - 70cc and 50cc. The 70cc product is FDA approved both as a destination therapy and a bridge to transplant. SynCardia also provides a portable driver, which powers the SynCardia Heart while allowing clinically stable patients to be discharged from the hospital to live at home. It claims to have over 1,400 implants accounting for more than 400 patient years. The company filed for an IPO in Aug 2015 and withdrew its application two months later.
Who are the top competitors of SynCardia?
SynCardia's top competitors include Sequana Medical, CVRx and Adona Medical.
What products or services does SynCardia offer?
SynCardia offers SynCardia Total Artificial Heart and Emperor Total Artificial Heart.
Who are SynCardia's investors?
SynCardia has 6 investors. Key investors include Delta Electronics, SWK Holdings, Athyrium Capital Management, Highway 12 Ventures, and Picardmedia.de.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.